Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous metoclopramide and gastric emptying in opium-using and non-using emergency patients
IRCT20210406050864N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of metoclopramide (3 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Gastric emptying. Started Sep 2021; status: completed.
02
Drugs
metoclopramide
Beyond the preview
Go deeper on IRCT20210406050864N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210406050864N1.